Published in Kidney Int on September 01, 1998
Oxidative Balance Score and Chronic Kidney Disease. Am J Nephrol (2015) 1.42
Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol (2014) 1.24
Determinants of renal disease variability in ADPKD. Adv Chronic Kidney Dis (2010) 1.11
Chronic renal disease. BMJ (2002) 1.06
New insights into the pathogenesis of IgA nephropathy. Semin Immunopathol (2014) 0.96
Environmental tobacco smoke furthers progression of diabetic nephropathy. Am J Med Sci (2011) 0.96
Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol (2010) 0.95
Association between smoking and chronic kidney disease: a case control study. BMC Public Health (2010) 0.95
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol (2017) 0.92
Cigarette smoking: an important renal risk factor - far beyond carcinogenesis. Tob Induc Dis (2002) 0.89
Identifying and slowing progressive chronic renal failure. Can Fam Physician (2001) 0.86
Renal agenesis and unilateral nephrectomy: what are the risks of living with a single kidney? Pediatr Nephrol (2008) 0.85
Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. Clin Exp Nephrol (2012) 0.85
The impact of disadvantage on the development and progression of diabetic kidney disease. Clin Nephrol (2010) 0.83
Nicotine signaling and progression of chronic kidney disease in smokers. Biochem Pharmacol (2013) 0.78
End-stage renal disease. BMJ Clin Evid (2010) 0.78
Differences in tobacco use between Canada and the United States. Int J Public Health (2009) 0.78
Clinical characteristics of male and female Korean patients with systemic lupus erythematosus: a comparative study. Korean J Intern Med (2015) 0.77
Update on immunoglobulin A nephropathy, Part I: Pathophysiology. World J Nephrol (2015) 0.76
Experimental therapies and ongoing clinical trials to slow down progression of ADPKD. Curr Hypertens Rev (2013) 0.76
Distal, intermediate, and proximal mediators of racial disparities in renal disease mortality in the United States. J Nephropathol (2015) 0.75
Tobacco exposure in children and adolescents with chronic kidney disease: parental behavior and knowledge. A study from the Midwest Pediatric Nephrology Consortium. Clin Nephrol (2014) 0.75
Smoking-Related Renal Histologic Injury in IgA Nephropathy Patients. Yonsei Med J (2016) 0.75
Current trends in European renal epidemiology. Clin Kidney J (2017) 0.75
Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study. Cardiovasc J Afr (2015) 0.75
Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos. Nephrol Dial Transplant (2016) 0.75
Ignoring the obvious missing piece of chronic kidney disease in HIV: cigarette smoking. J Assoc Nurses AIDS Care (2009) 0.75
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis. PLoS One (2017) 0.75
Uncontrolled hypertension among patients managed in primary healthcare facilities in Kinshasa, Democratic Republic of the Congo. Cardiovasc J Afr (2016) 0.75
An alternative empirical likelihood method in missing response problems and causal inference. Stat Med (2016) 0.75
Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus Erythematosus. PLoS One (2015) 0.75
End stage renal disease. BMJ Clin Evid (2007) 0.75
Homocysteine in Renal Injury. Kidney Dis (Basel) (2016) 0.75
Cigarette Smoking and Its Hazards in Kidney Transplantation. Adv Med (2017) 0.75
Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan. Evid Based Complement Alternat Med (2017) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int (2007) 4.68
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet (2001) 3.62
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int (1999) 3.26
The nephrotic syndrome. N Engl J Med (1998) 3.22
Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98
Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42
Hantavirus infection presenting as acute renal failure. Lancet (1990) 2.40
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant (2000) 2.38
Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1984) 2.26
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol (1998) 2.21
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients. J Thromb Haemost (2012) 2.17
The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. Nephrol Dial Transplant (1995) 2.06
Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest (1989) 1.98
Randomized clinical trial of laparoscopic cholecystectomy performed with mini-instruments. Br J Surg (2003) 1.98
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med (2013) 1.96
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int (2007) 1.83
A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1989) 1.83
Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int (2006) 1.82
Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein. Mol Cell Biol (1997) 1.82
Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N Engl J Med (1992) 1.81
Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2006) 1.79
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int (1998) 1.77
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int (1995) 1.74
Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant (1998) 1.71
Oscillation and noise determine signal transduction in shark multimodal sensory cells. Nature (1994) 1.70
First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying. Gut (1998) 1.68
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res (1998) 1.63
Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig (1992) 1.61
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int (1998) 1.61
Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost (1984) 1.59
Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem (2000) 1.59
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58
Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant (1995) 1.54
Increased rectal cell proliferation following alcohol abuse. Gut (2001) 1.49
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int (2001) 1.49
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48
Prospective study on captopril renography in hypertensive patients. Am J Nephrol (1992) 1.47
Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J Pharmacol (1999) 1.47
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Eur Respir J (2008) 1.46
Retroperitoneal lymphangiectasia associated with bilateral renal vein thrombosis. Nephrol Dial Transplant (1997) 1.45
TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene (1998) 1.45
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43
Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. Nephron (1994) 1.42
Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis. Nephrol Dial Transplant (1989) 1.42
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Perit Dial Int (1996) 1.42
How to save money for erythropoietin therapy by changing from 'roller coaster' to continuous iron supplementation. Nephron (1999) 1.42
Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest (2001) 1.41
[Organ preservation in advanced laryngeal and hypopharyngeal carcinoma by primary radiochemotherapy. Results of a multicenter phase II study]. HNO (2002) 1.41
Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function. Eur J Clin Invest (1998) 1.41
The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. Nephrol Dial Transplant (1992) 1.41
Parathyroidectomy in secondary (renal) hyperparathyroidism--whom, when, how? Int J Artif Organs (1993) 1.41
[Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. Dtsch Med Wochenschr (1995) 1.40
Horseshoe kidney. Nephrol Dial Transplant (1999) 1.40
Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation (2001) 1.39
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39
Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients. Perit Dial Int (1996) 1.39
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. Dtsch Med Wochenschr (2004) 1.39
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
[Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. Dtsch Med Wochenschr (2003) 1.39
C-reactive protein and coronary artery disease-what is the link? Nephrol Dial Transplant (1999) 1.39
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant (1991) 1.38
Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) Eur J Clin Invest (1989) 1.38
[Cardiovascular risk factors in diabetic nephropathy]. Med Klin (Munich) (1997) 1.38
Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38
A patient with evidence of two underlying diseases causing hypercalcaemia. Nephrol Dial Transplant (2001) 1.38
The patient with acute renal failure and nondilated urinary tract. Nephrol Dial Transplant (1998) 1.38
Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats. Eur J Clin Invest (1999) 1.38
[The quality of the treatment of diabetics in kidney failure in Germany]. Dtsch Med Wochenschr (2000) 1.38
What is the role of sensitization in uremic pruritus? An allergologic study. Nephron (1991) 1.38
Regulation of base balance in bicarbonate hemofiltration. Int J Artif Organs (1994) 1.38
Comparing frontal cranial profiles in archaic and modern homo by morphometric analysis. Anat Rec (1999) 1.38
Effect of menthol on cold receptor activity. Analysis of receptor processes. J Gen Physiol (1986) 1.38
Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study. Clin Nephrol (1993) 1.37
Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol (1998) 1.37
Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol (1982) 1.37
The Normal Haematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin? Nephrol Dial Transplant (1998) 1.36
Bone histology in incipient and advanced renal failure. Kidney Int (1976) 1.35
Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr (1974) 1.34
Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int (1999) 1.33
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol (2000) 1.32
Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant (1992) 1.30
Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol (1997) 1.30
Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant (1990) 1.30
A second genetic locus for autosomal dominant polycystic kidney disease. Lancet (1988) 1.29
1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood (1993) 1.28